VanEck Pharmaceutical ETF PPH

Full chart Compare
Set alert

Price alert · PPH

All alert types
120.05 USD +1.45 (+1.22%)

Nov 4, 2026, 10:16 AM EST

119.63 Day range 121.50
92.60 52-week range 121.50
YTD
+16.36%
1 year
+29.43%

VanEck Pharmaceutical ETF

Issuer
VanEck
Asset class
Equity
Expense ratio
0.36%
Assets under management
$1.13B
NAV
118.58
Holdings
26
Inception
2011-12-20
Top 10 weight
72.19%

Top holdings

  1. LLY Eli Lilly & Co 23.16%
  2. MRK Merck & Co Inc 12.48%
  3. NVO Novo Nordisk A/S 5.48%
  4. PFE Pfizer Inc 5.09%
  5. MCK Mckesson Corp 4.65%
  6. BMY Bristol-Myers Squibb Co 4.51%
  7. TEVA Teva Pharmaceutical Industries Ltd 4.48%
  8. COR Cencora Inc 4.34%
  9. GSK Gsk Plc 4.19%
  10. AZN Astrazeneca Plc 3.80%
  11. NVS Novartis Ag 3.75%
  12. ABBV Abbvie Inc 3.67%
  13. SNY Sanofi Sa/France 3.39%
  14. HLN Haleon Plc 3.30%
  15. JNJ Johnson & Johnson 3.23%
  16. TAK Takeda Pharmaceutical Co Ltd 2.86%
  17. ZTS Zoetis Inc 2.70%
  18. VTRS Viatris Inc 1.45%
  19. JAZZ Jazz Pharmaceuticals Plc 1.12%
  20. AXSM Axsome Therapeutics Inc 0.50%
  21. CORT Corcept Therapeutics Inc 0.49%
  22. ELAN Elanco Animal Health Inc 0.49%
  23. DFTX Definium Therapeutics Inc 0.38%
  24. OGN Organon & Co 0.27%
  25. PRGO Perrigo Co Plc 0.10%

Sector weights

  • Healthcare 100.00%

Country weights

  • United States 68.88%
  • United Kingdom 11.15%
  • Denmark 5.41%
  • Israel 4.66%
  • Switzerland 3.82%
  • France 3.28%
  • Japan 2.79%

Updated 2026-11-04

Held by funds

3 US ETFs and mutual funds hold PPH · largest positions

Funds holding PPH, by value held
FundValue heldWeight in fund
LRND $2.43M0.58%
LCR $696.54K1.07%
EMSG $21.50K0.07%